We are live on ! Find out more
LIM

Leavell Investment Management Portfolio holdings

AUM $2.74B
1-Year Est. Return 26.51%
This Fund
S&P 500
This Quarter Est. Return
+9.72%
1 Year Est. Return
+26.51%
3 Year Est. Return
+84.54%
5 Year Est. Return
+103.52%
10 Year Est. Return
+312.79%
AUM
$1.57B
AUM Growth
+$143M
Cap. Flow
+$12.5M
Cap. Flow %
0.8%
Top 10 Hldgs %
23.46%
Holding
483
New
30
Increased
152
Reduced
168
Closed
21
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IUSB icon
151
iShares Core Universal USD Bond ETF
IUSB
$43.3B
$2.17M 0.14%
47,039
+15,627
+50% +$691K
BA icon
152
Boeing
BA
$185B
$2.14M 0.14%
8,216
+2,670
+48% +$571K
SHEL icon
153
Shell
SHEL
$245B
$2.13M 0.14%
32,448
+699
+2% +$45.9K
PWR icon
154
Quanta Services
PWR
$101B
$2.13M 0.14%
9,862
+650
+7% +$120K
GIS icon
155
General Mills
GIS
$19.7B
$2.13M 0.14%
32,674
-2,134
-6% -$138K
BNRE.A
156
DELISTED
Brookfield Reinsurance Ltd. Class A-1 Exchangeable Non-Voting Shares
BNRE.A
$2.13M 0.14%
+53,068
New +$1.97M
BSCQ icon
157
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.57B
$2.11M 0.13%
109,403
+6,859
+7% +$130K
DVN icon
158
Devon Energy
DVN
$47.3B
$2.1M 0.13%
46,347
-20,535
-31% -$940K
IDEV icon
159
iShares Core MSCI International Developed Markets ETF
IDEV
$32.6B
$2.1M 0.13%
32,980
+2,110
+7% +$126K
MS icon
160
Morgan Stanley
MS
$340B
$2.09M 0.13%
22,412
+1,120
+5% +$89.6K
PFE icon
161
Pfizer
PFE
$153B
$2.06M 0.13%
71,532
-10,782
-13% -$326K
BR icon
162
Broadridge
BR
$19B
$2.04M 0.13%
9,895
-280
-3% -$51.7K
ORI icon
163
Old Republic International
ORI
$10.4B
$2.04M 0.13%
69,475
-318
-0.5% -$8.95K
IBM icon
164
IBM
IBM
$224B
$2.04M 0.13%
12,462
-100
-0.8% -$15.1K
DCRE icon
165
DoubleLine Commercial Real Estate Debt ETF
DCRE
$459M
$2.03M 0.13%
+39,929
New +$2.02M
CCJ icon
166
Cameco
CCJ
$42.4B
$2.02M 0.13%
46,950
+33,000
+237% +$1.38M
COWZ icon
167
Pacer US Cash Cows 100 ETF
COWZ
$19.4B
$2.01M 0.13%
38,461
+16,800
+78% +$835K
GEHC icon
168
GE HealthCare
GEHC
$32.4B
$2M 0.13%
25,819
+1,500
+6% +$105K
SCHG icon
169
Schwab US Large-Cap Growth ETF
SCHG
$62.9B
$1.99M 0.13%
95,820
+45,588
+91% +$882K
VYM icon
170
Vanguard High Dividend Yield ETF
VYM
$83.5B
$1.98M 0.13%
17,738
-3,211
-15% -$337K
AJG icon
171
Arthur J. Gallagher & Co
AJG
$63.6B
$1.96M 0.12%
8,717
META icon
172
Meta Platforms (Facebook)
META
$1.51T
$1.92M 0.12%
5,437
+529
+11% +$172K
DHR icon
173
Danaher
DHR
$144B
$1.92M 0.12%
8,302
-983
-11% -$209K
MLM icon
174
Martin Marietta Materials
MLM
$33B
$1.92M 0.12%
3,850
UNP icon
175
Union Pacific
UNP
$174B
$1.87M 0.12%
7,610
-246
-3% -$54.1K

Similar funds

Leavell Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Leavell Investment Management held 483 positions worth $1.57B, up 10% from $1.43B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Leavell Investment Management's Q4 2023 filing shows 30 new, 152 increased, 168 reduced and 21 closed positions. Its largest new stake was iShares MSCI ACWI ETF: 50,345 shares worth $5.12M. The largest sale was iShares iBonds Dec 2023 Term Corporate ETF, an estimated $9.98M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.

  • Leavell Investment Management's largest Q4 2023 buy was iShares MSCI ACWI ETF: 50,345 shares worth $5.12M.
  • Leavell Investment Management added most to Vanguard Total World Stock ETF in Q4 2023, an estimated $4.84M increase.
  • Leavell Investment Management's biggest Q4 2023 reduction was iShares iBonds Dec 2024 Term Muni Bond ETF, cutting an estimated $2.45M.
  • Leavell Investment Management fully exited iShares iBonds Dec 2023 Term Corporate ETF in Q4 2023, selling an estimated $9.98M.
  • Leavell Investment Management's ten largest holdings make up 23% of its $1.57B portfolio in Q4 2023.
  • Leavell Investment Management opened 30 new positions and closed 21 in Q4 2023.
  • Leavell Investment Management's portfolio value rose 10% quarter-over-quarter to $1.57B.

Based on Leavell Investment Management's 13F filing for Q4 2023, filed 23 Jan 2024.